RJ
Rakeshkumar Jatashankar Pathak
About Rakeshkumar Jatashankar Pathak
Data last updated:
Rakeshkumar Jatashankar Pathak is a Director at Iba Particle Therapy India Private Limited (since 2017) and Designated Partner at International Business Excellence & Advisory Services Llp (since 2013). The companies operate in Healthcare, Business Services and Consumer Electronics & Durables. The largest current company by reported revenue is Iba Particle Therapy India Private Limited at ₹46.90 Cr (FY 2025). Earlier, Rakeshkumar Jatashankar Pathak was a Director at Design Cell Panel Private Limited (2006–2012) and Director at Merint Molecular Imaging Private Limited (2006–2012) and 5 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Iba Particle Therapy India Private Limited U74900TN2013FTC094391 | Director | 04 Jul 2017 | 2013 | ₹46.90 Cr (FY 2025) | Active |
| Designated Partner | 07 Nov 2013 | 2013 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Design Cell Panel Private Limited U36100MH2001PTC133943 | Director | 20 Nov 2006 | 2001 | Converted To Llp | |
 Merint Molecular Imaging Private Limited U74999MH2006PTC163467 | Director | 02 Aug 2006 | 2006 | ₹4.6 Lakh (FY 2020) | Active |
 Merint Industrial Infrastructure Private Limited U45201MH2007PTC172080 | Director | 29 Jun 2007 | 2007 | ₹85.6 Lakh (FY 2025) | Active |
 Merint Developers Private Limited U74999MH1998PTC112762 | Director | 29 Mar 2006 | 1998 | ₹1.57 Cr (FY 2025) | Active |
| Givp Engineering Private Limited U45200MH2005PTC151030 | Director | 04 Feb 2005 | 2005 | ₹1.3 Lakh (FY 2021) | Active |
 Curium Pharma (India) Private Limited U24230MH2004PTC150212 | Director | 24 Dec 2004 | 2004 | ₹41.38 Cr (FY 2025) | Active |
| Rawaat Buildcon India Private Limited U45202MH2010PTC209344 | Director | 22 Oct 2010 | 2010 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rakeshkumar Jatashankar Pathak
| Name | DIN | Company | Designation |
|---|---|---|---|
| Henri Baudry C De Romree De Vichenet | 11133198 | Iba Particle Therapy India Private Limited | Director |
| Olivier Jacques G Legrain | 03031690 | Iba Particle Therapy India Private Limited | Director |
| Soumya Chandramouli | 08068471 | Iba Particle Therapy India Private Limited | Director |
| Anupama Rakesh Kumar Pathak | 03126022 | International Business Excellence & Advisory Services Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rakeshkumar Jatashankar Pathak
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rakeshkumar Jatashankar Pathak
Rakeshkumar Jatashankar Pathak currently holds 2 directorships: Iba Particle Therapy India Private Limited (Director, since 04 Jul 2017, revenue ₹46.90 Cr (FY 2025)); International Business Excellence & Advisory Services Llp (Designated Partner, since 07 Nov 2013).
Rakeshkumar Jatashankar Pathak was first appointed on 24 Dec 2004 as Director at Curium Pharma (India) Private Limited. The most recent appointment on record is 04 Jul 2017 at Iba Particle Therapy India Private Limited.
Rakeshkumar Jatashankar Pathak held 7 earlier board appointments: Design Cell Panel Private Limited (Director, 20 Nov 2006 to 19 Sep 2012); Merint Molecular Imaging Private Limited (Director, 02 Aug 2006 to 19 Sep 2012); Merint Industrial Infrastructure Private Limited (Director, 29 Jun 2007 to 19 Sep 2012); Merint Developers Private Limited (Director, 29 Mar 2006 to 19 Sep 2012); Givp Engineering Private Limited (Director, 04 Feb 2005 to 24 Aug 2013); and 2 more.
The current boards of Rakeshkumar Jatashankar Pathak's companies include Henri Baudry C De Romree De Vichenet (Iba Particle Therapy India Private Limited), Olivier Jacques G Legrain (Iba Particle Therapy India Private Limited), Soumya Chandramouli (Iba Particle Therapy India Private Limited), Anupama Rakesh Kumar Pathak (International Business Excellence & Advisory Services Llp).